Microglia act as sensors of inflammation in the central nervous system (CNS) and respond to many stimuli. Other key players in neuroinflammatory diseases are CD4 + T helper cell (Th) subsets that characteristically secrete IFN-c (Th1) or IL-17 (Th17). However, the potential of a distinct cytokine milieu generated by these effector T cell subsets to modulate microglial phenotype and function is poorly understood. We therefore investigated the ability of factors secreted by Th1 and Th17 cells to induce microglial activation. In vitro experiments wherein microglia were cultured in the presence of supernatants derived from polarized Th1 or Th17 cultures, revealed that Th1-associated factors could directly activate and trigger a proinflammatory M1-type gene expression profile in microglia that was cell-cell contact independent, whereas Th17 cells or its associated factors did not have any direct influence on microglia. To assess the effects of the key Th17 effector cytokine IL-17A in vivo we used transgenic mice in which IL-17A is specifically expressed in astrocytes. Flow cytometric and histological analysis revealed only subtle changes in the phenotype of microglia suggesting only minimal effects of constitutively produced IL-17A on microglia in vivo. Neither IL-23 signaling nor addition of GM-CSF, a recently described effector molecule of Th17 cells, changed the incapacity of Th17 cells to activate microglia. These findings demonstrate a potent effect of Th1 cells on microglia, however, the mechanism of how Th17 cells achieve their effect in CNS inflammation remains unclear.
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Introduction
Neuroinflammation is a consequence of a crosstalk between resident immune cells of the CNS and cells infiltrating from the periphery (Ransohoff and Brown, 2012; Ransohoff and Engelhardt, 2012) . Microglia are crucial in maintaining the integrity of the CNS, as they constantly sample the microenvironment and act as sensors of pathological conditions. The activation state of microglia strikes a balance between tissue damage and repair. In steady state, the resting microglia express low levels of major histocompatibility complex (MHC) class II molecules and co-stimulatory molecules on their surface and are mostly involved in maintenance of homeostasis in CNS (Aguzzi et al., 2013; Goldmann and Prinz, 2013; Tambuyzer et al., 2009 ). However, an inflammatory insult leads to activation of microglia and triggers a proinflammatory cascade that can cause tissue damage. Reports suggest that microglial activation is a key event in most of the neuroinflammatory and neurodegenerative disorders (Bhasin et al., 2007; Heppner et al., 2005) .
It is well understood that IFN-c-producing Th1 cells and IL-17-producing Th17 cells play a crucial role in the pathology of multiple sclerosis (MS), experimental autoimmune encephalomyelitis (EAE) and similar neurodegenerative disorders (Goverman, 2009; Pierson et al., 2012) . The individual contribution of Th1 and Th17 cells in CNS pathologies is highly debatable but a consensus arises from the fact that both subsets can mediate EAE although with varying degree of severity when adoptively transferred into mice (Domingues et al., 2010; Gocke et al., 2007; Lee et al., 2012; Yang et al., 2009) . Characteristically, these subsets have distinct cytokine secretory profiles as their differentiation is controlled by mutually
